INTERFERON ALFA-2A is a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed b Amarillo Biosciences. The substance is available for sale in the form of a gel, powder, and solvent for solution for injection, vials, solution for injection, nasal spray, nasal drops, pre-filled syringe, from manufacturers in various countries including Y. The drug is provided by a wide range of INTERFERON ALFA-2A suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading INTERFERON ALFA-2A manufacturers and distributors are based in China. Under the trade names Pegasys, the medication’s recombinant form was approved by the EMA in the European Union in 2002. The medication was approved by FDA in the USA in the same year. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Roferon A Soln, Roferon A Sterile, Roferon-A, Roferon-A Sol. One of the most popular branded versions of INTERFERON ALFA-2A is manufactured and supplied by the Chinese pharmaceutical company Ningbo distant chemicals co.,ltd. Other manufacturing companies and distributors from European Union, Argentina, Brazil, Ukraine, Vietnam have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with INTERFERON ALFA-2A as an active ingredient.

Some forms of leukaemia are also treated with interferon alfa-2a (cancer of the white blood cells). The class of medications known as interferons includes interferon alfa-2a. Interferons function by thwarting viruses in the body and controlling cell growth. T lymphocytes and other immune system cells are encouraged to attack the tumour by interferon alfa. Additionally, it might induce cancer cells to release substances that draw immune system cells to them.

An online search for the wholesale price for sale of Interferon Alfa-2A for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The wholesale acquisition cost of Pegasys subcutaneous solution (180 mcg/mL) is around $1,076 for a supply of 1 milliliter(s). The retail price of Pegasys 180mcg / 0.5ml solution for injection in a pre-filled syringe N1 + 1 injection needle in Europe reaches 188.14 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Interferon Alfa-2A distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Interferon Alfa-2A suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Interferon Alfa-2A. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Interferon Alfa-2A is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Interferon Alfa-2A suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Interferon Alfa-2A Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

INTERFERON ALFA-2A is a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed b Amarillo Biosciences. The substance is available for sale in the form of a gel, powder, and solvent for solution for injection, vials, solution for injection, nasal spray, nasal drops, pre-filled syringe, from manufacturers in various countries including Y. The drug is provided by a wide range of INTERFERON ALFA-2A suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading INTERFERON ALFA-2A manufacturers and distributors are based in China. Under the trade names Pegasys, the medication’s recombinant form was approved by the EMA in the European Union in 2002. The medication was approved by FDA in the USA in the same year. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Roferon A Soln, Roferon A Sterile, Roferon-A, Roferon-A Sol. One of the most popular branded versions of INTERFERON ALFA-2A is manufactured and supplied by the Chinese pharmaceutical company Ningbo distant chemicals co.,ltd. Other manufacturing companies and distributors from European Union, Argentina, Brazil, Ukraine, Vietnam have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with INTERFERON ALFA-2A as an active ingredient.

Some forms of leukaemia are also treated with interferon alfa-2a (cancer of the white blood cells). The class of medications known as interferons includes interferon alfa-2a. Interferons function by thwarting viruses in the body and controlling cell growth. T lymphocytes and other immune system cells are encouraged to attack the tumour by interferon alfa. Additionally, it might induce cancer cells to release substances that draw immune system cells to them.

An online search for the wholesale price for sale of Interferon Alfa-2A for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The wholesale acquisition cost of Pegasys subcutaneous solution (180 mcg/mL) is around $1,076 for a supply of 1 milliliter(s). The retail price of Pegasys 180mcg / 0.5ml solution for injection in a pre-filled syringe N1 + 1 injection needle in Europe reaches 188.14 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Interferon Alfa-2A distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Interferon Alfa-2A suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Interferon Alfa-2A. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Interferon Alfa-2A is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Interferon Alfa-2A suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Interferon Alfa-2A Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.